Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002090:Butyrophenones / Q000627:therapeutic use*; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy; D005461:Fluorine / Q000627:therapeutic use*; D006213:Hallucinogens / Q000652:urine*; D006801:Humans; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy / Q000652:urine*; D014272:Trifluperidol / Q000627:therapeutic use
D000928:Antidepressive Agents; D002090:Butyrophenones; D006213:Hallucinogens; D010880:Piperidines; D005461:Fluorine; D014272:Trifluperidol